WELLBUTRIN: payments to doctors
Payments that named WELLBUTRIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $650K
- Providers
- 10,056
- Transactions
- 39,238
- Average per transaction
- $17
The per-transaction average — $17 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,056 providers the average total is $65, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bausch Health US, LLC | $650,342 | 100.0% |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $100 | 0.0% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $13 | 0.0% |